TY - JOUR
T1 - Narrative exploration of uncontrolled asthma: insights from patients and healthcare professionals in a cross-sectional study
AU - Piraino, Alessio
AU - Pennisi, Vincenzo
AU - Volpato, Eleonora
AU - Pennisi, Alfio
AU - Banfi, Paolo I.
AU - D'Antonio, Salvatore
AU - Centanni, Stefano
AU - Bugliaro, Filomena
AU - Cappuccio, Antonietta
AU - Cavalieri, Luca
AU - Ramaccia, Mattia
AU - Termini, Roberta
AU - Marini, Maria Giulia
AU - Ramaccia, Mattia
PY - 2024
Y1 - 2024
N2 - Background: Despite effective inhalation therapy, uncontrolled asthma remains prevalent. Narrative Medicine (NM) seeks to understand illness experiences linguistically, providing a framework to enhance healthcare.
Aims: To gather narratives from uncontrolled asthma patients and Health Care Professionals (HCPs), exploring treatment decisions, adherence factors, emotions, economic burdens, and comprehensive care.
Methods: A cross-sectional NM study was conducted in Italy (February-December 2023), involving 135 uncontrolled asthma patients [54.7% male; mean age:56.7 years] and 47 HCPs [64.9% male; mean age: 54.3 years]. A mixed-method approach was adopted to examine themes, language, emotions, and narrative classifications.
Results: The patients reported an average illness duration of 4.46 years, with worsening occurring over the last 20.9 months. Pulmonologists (83% of HCPs) took a primary role in diagnosing and treating the disease in 96.1% of patients. Additionally, 51 patients reported incurring extra costs in the treatment of their asthma. The most frequent reported feelings were tiredness (25.96%) and feeling suffocated (11.53%). Once they started treatment, although feeling better physically, they mostly experience emotion of "submission/dependence" on the drug (28%), followed by "fear" (21%) and "serenity/joy" (21%). The HCPs, mainly pulmonologists (83%), emphasized the need for increased specialist and general practitioner awareness, including information dissemination, attention to prescriptions, phenotyping, targeted therapy, and paediatric considerations.
Conclusions: The findings enhance patient understanding, personalize interventions, and highlight factors influencing therapeutic adherence.
AB - Background: Despite effective inhalation therapy, uncontrolled asthma remains prevalent. Narrative Medicine (NM) seeks to understand illness experiences linguistically, providing a framework to enhance healthcare.
Aims: To gather narratives from uncontrolled asthma patients and Health Care Professionals (HCPs), exploring treatment decisions, adherence factors, emotions, economic burdens, and comprehensive care.
Methods: A cross-sectional NM study was conducted in Italy (February-December 2023), involving 135 uncontrolled asthma patients [54.7% male; mean age:56.7 years] and 47 HCPs [64.9% male; mean age: 54.3 years]. A mixed-method approach was adopted to examine themes, language, emotions, and narrative classifications.
Results: The patients reported an average illness duration of 4.46 years, with worsening occurring over the last 20.9 months. Pulmonologists (83% of HCPs) took a primary role in diagnosing and treating the disease in 96.1% of patients. Additionally, 51 patients reported incurring extra costs in the treatment of their asthma. The most frequent reported feelings were tiredness (25.96%) and feeling suffocated (11.53%). Once they started treatment, although feeling better physically, they mostly experience emotion of "submission/dependence" on the drug (28%), followed by "fear" (21%) and "serenity/joy" (21%). The HCPs, mainly pulmonologists (83%), emphasized the need for increased specialist and general practitioner awareness, including information dissemination, attention to prescriptions, phenotyping, targeted therapy, and paediatric considerations.
Conclusions: The findings enhance patient understanding, personalize interventions, and highlight factors influencing therapeutic adherence.
KW - Narrative Medicine
KW - Adherence
KW - Uncontrolled Asthma
KW - Severe Asthma
KW - Narrative Medicine
KW - Adherence
KW - Uncontrolled Asthma
KW - Severe Asthma
UR - http://hdl.handle.net/10807/298197
UR - https://publications.ersnet.org/content/erj/64/suppl68/pa1177
U2 - 10.1183/13993003.congress-2024.pa1177
DO - 10.1183/13993003.congress-2024.pa1177
M3 - Conference article
SN - 0903-1936
VL - 64
SP - N/A-N/A
JO - European Respiratory Journal
JF - European Respiratory Journal
T2 - European Respiratory Society (ERS) Congress 2024
Y2 - 7 September 2024 through 11 September 2024
ER -